The use of bromocriptine in the galactorrhoea-amenorrhoea syndromes: the Canadian cooperative study.

作者信息

Friesen H G, Tolis G

出版信息

Clin Endocrinol (Oxf). 1977;6 Suppl:91S-99S. doi: 10.1111/j.1365-2265.1977.tb03343.x.

DOI:10.1111/j.1365-2265.1977.tb03343.x

PMID:617073

Abstract

摘要

相似文献

The use of bromocriptine in the galactorrhoea-amenorrhoea syndromes: the Canadian cooperative study.

Clin Endocrinol (Oxf). 1977;6 Suppl:91S-99S. doi: 10.1111/j.1365-2265.1977.tb03343.x.

Bromocriptine-induced pregnancies in the amenorrhoea-galactorrhoea syndrome.

Med J Malaysia. 1983 Sep;38(3):237-43.

2alpha-bromoergocryptine in the management of the amenorrhea-galactorrhea syndrome. Clinical and endocrinological evaluation of response to treatment.

Acta Eur Fertil. 1978 Mar;9(1):21-9.

[Bromocriptine treatment of amenorrhea with hyperprolactinemia and galactorrhea].

Horumon To Rinsho. 1983 Jan;31(1):95-9.

[Bromocriptine treatment of infertile women with amenorrhoea--galactorrhoea].

Lakartidningen. 1977 Nov 16;74(46):4110-2.

[Treatment of the amenorrhea-galatorrhea-anovulation syndrome with bromocryptin and the results].

Akush Ginekol (Sofiia). 1980;19(1):46-52.

Pyridoxine treatment of galactorrhoea-amenorrhoea syndromes.

Acta Endocrinol (Copenh). 1978 Apr;87(4):682-6. doi: 10.1530/acta.0.0870682.

[Treatment of amenorrhea-galactorrhea with bromo-ergocryptine. Apropos of 12 cases].

J Gynecol Obstet Biol Reprod (Paris). 1977 Jun;6(4):537-46.

Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.

Acta Neurol (Napoli). 1980 Feb;2(1):15-22.

Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.

Adv Biochem Psychopharmacol. 1980;23:209-15.

引用本文的文献

How to manage intolerance to dopamine agonist in patients with prolactinoma.

Pituitary. 2023 Apr;26(2):187-196. doi: 10.1007/s11102-023-01313-8. Epub 2023 Apr 7.

Pharmacologic resistance in prolactinoma patients.

Pituitary. 2005;8(1):43-52. doi: 10.1007/s11102-005-5085-2.

Dopamine resistance of prolactinomas.

Pituitary. 2003;6(1):19-27. doi: 10.1023/a:1026225625897.

Nasal spray vs oral administration of bromocriptine: pharmacology and effect on serum prolactin in puerperal women.

J Endocrinol Invest. 1996 Jul-Aug;19(7):427-32. doi: 10.1007/BF03349887.

Prolactinoma in 53 men: clinical characteristics and modes of treatment (male prolactinoma).

J Endocrinol Invest. 1995 Jun;18(6):436-41. doi: 10.1007/BF03349742.

Prolactin-secreting pituitary adenomas.

West J Med. 1983 Nov;139(5):663-72.

Cushing's disease: clinical and laboratory response to bromocriptine therapy.

J Endocrinol Invest. 1984 Dec;7(6):585-8. doi: 10.1007/BF03349490.

Treatment of patients with prolactinomas.

J Endocrinol Invest. 1978 Jan;1(1):47-58. doi: 10.1007/BF03346770.

Prolactin oversuppression.

Arch Gynakol. 1977 Oct 28;223(3):173-8. doi: 10.1007/BF00667386.

Use of bromocriptine in hyperprolactinaemic anovulation and related disorders.

Drugs. 1979 May;17(5):337-48. doi: 10.2165/00003495-197917050-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验